<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02299466</url>
  </required_header>
  <id_info>
    <org_study_id>03-0845-AE</org_study_id>
    <nct_id>NCT02299466</nct_id>
  </id_info>
  <brief_title>Registry for Patients Receiving Intravenous Nutrition at Home</brief_title>
  <acronym>HTPN</acronym>
  <official_title>Home Total Parenteral Nutrition (HTPN) in Canada: A New Website Based Patient Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Nutrition Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ontario Medical Suppy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of study is to build a Canadian HTPN Registry to collect pertinent demographic
      and clinical data on the HTPN population in Canada and to determine the factors affecting
      survival, complications and TPN-dependency. These results will help establish standards of
      practice and develop future multi-center studies. This will greatly benefit the HTPN patient
      population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The HTPN Registry is website based. Only users inside of Canada will be able to access the
      website. All data is held in Ontario, Canada and is governed by Ontario and Canadian privacy
      and security laws. The entry point into the registry will be through a website
      www.htpnregistry.ca, using a specific HTPN program password for data entry. A code and date
      of birth will be used to identify each patient. Patient data will be kept confidential and be
      entered by a member of the TPN team from each participating program. Participating programs
      will have access to their own database and will be able to compare their patient population
      to the one of the entire registry. Data entered into the registry will include: 1) Patient
      demography 2) Nutritional assessment 3) Medications 4) Indications for HTPN 5)
      Gastrointestinal anatomy following surgeries 6) HTPN regimen 7) Current blood work 8)
      Vascular access 9) Hospitalizations 10) Survival, 11) Liver complications 12) Metabolic bone
      disease 13) quality of life. In addition, information regarding each HTPN program will be
      captured: organization of the TPN team, number of patients under the program, diagnosis and
      reasons for HTPN, source of funding, geographical coverage, home care utilization, providers.
      Data will be entered every two years by the one or more HTPN staff monitoring the patients.
      The data can be entered directly into the website or case report forms can be used to collect
      the data from the patient charts and facilitate data input into the website.

      All patients will be followed prospectively until discontinuation of TPN or death.
      Descriptive statistics will be performed.

      For the entire HTPN population, probability of survival, chronic cholestasis, complicated
      home parenteral nutrition related liver disease, line infection and metabolic bone disease
      will be calculated using the Kaplan-Meier method. As of February 2014, 433 patients (85 from
      UHN) have been entered into the Canadian HTPN registry. The recruitment and data collection
      is expected to continue for at least 5 more years (until 2019). Participating HTPN programs
      are: Toronto (Toronto General Hospital, St. Michael's Hospital), Hamilton (Hamilton Health
      Sciences),Winnipeg (St. Boniface General Hospital), Edmonton (Capital Health/University Of
      Alberta), Calgary (Foothills Medical Centre), British Columbia (BC Home Parenteral Nutrition
      Program) and Montreal (McGill University).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2005</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>15 Years</target_duration>
  <primary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Body weight, body mass index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient characteristics</measure>
    <time_frame>baseline</time_frame>
    <description>Age, sex, medical history</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medications</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Immunosuppressors, motility agents, antidiarrheal, sedatives, antidepressors, anticoagulants, insulin, inhibitors of acid secretion, medication to treat liver disease (eg. urso, carnitine, choline…), medication to treat metabolic bone disease (eg. iv/oral calcium, vitamin D, biphosphonate, calcitonin,… are collected from the charts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Indications for HTPN</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Short bowel, motility disorder, cancer, surgical complications, pancreatic disorders, other causes of malabsorption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal anatomy</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Anatomy as described in medical records</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HTPN regimen</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Energy, amino acids, lipids, fluid, electrolytes, vitamins, trace elements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Current blood work</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Complete blood count , biochemistry including liver enzymes, total protein, albumin, prealbumin, vit B12, red blood cell folate, iron studies,international normalized ratio /prothrombin time /partial thromboplastin time , cholesterol, triglycerides, trace elements;parathyroid hormone , 24-hr urine oxalate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular access</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>type of catheter, number of lumens, changes in vascular access, complications (line sepsis, occlusion)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalizations</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Number/year and TPN related or not TPN related</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Alive, death: causes, TPN-related or not TPN-related</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver complications</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Diagnosis, abdominal ultrasound results, liver biopsy results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic Bone Disease</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Bone mineral density results, fracture risk and reported fractures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>bi-annually up to 10 years, discontinuation of HTPN or death</time_frame>
    <description>Karnofsky performance scale</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Parenteral Nutrition, Home</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients receiving home total parenteral nutrition (HTPN)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with long-term administration of home total parenteral nutrition Age &gt;18
             years

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johane Allard, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Johane Allard, MD,FRCPC</last_name>
    <phone>416-340-5159</phone>
    <email>johane.allard@uhn.on.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Monica L Ponta, MD</last_name>
    <phone>+1-416-340-4413</phone>
    <email>monica.ponta@uhnresearch.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maitreyi Raman, MD</last_name>
      <phone>403-943-2580</phone>
      <email>mkothand@ucalgary.ca</email>
    </contact>
    <contact_backup>
      <last_name>Sari Czink, RD</last_name>
      <phone>403-944-1638</phone>
      <email>Sari.czink@calgaryhealthregion.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Captial Health/University Of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leah Gramlich, MD</last_name>
      <phone>780-735-6839</phone>
      <email>eah.gramlich@ualberta.ca</email>
    </contact>
    <contact_backup>
      <last_name>Holly Ames, RD</last_name>
      <phone>780-407-6021</phone>
      <email>holly.ames@albertahealthservices.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>BC Home Parenteral Nutrition Program</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Whittaker, MD</last_name>
      <phone>604-688-6332 x226</phone>
      <email>scottwhittaker@mac.com</email>
    </contact>
    <contact_backup>
      <last_name>Holly van Heukelom</last_name>
      <phone>604-806-9808</phone>
      <email>HvanHeukelom@providencehealth.bc.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Boniface General Hospital</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H 2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald Duerksen, MD</last_name>
      <email>dduerkse@sbgh.mb.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Armstrong, MD</last_name>
      <email>armstro@mcmaster.ca</email>
    </contact>
    <contact_backup>
      <last_name>Suzanne Hansen, RD</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>75358</phone_ext>
      <email>shansen@hhsc.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khursheed Jeejeebhoy, MD</last_name>
      <phone>416-864-5348</phone>
      <email>khushjeejeebhoy@compuserve.com</email>
    </contact>
    <contact_backup>
      <last_name>Brian Jurewitsch, RN</last_name>
      <phone>416.864.5431</phone>
      <email>jurewitschb@smh.toronto.on.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hopital St-Luc</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H2X 0C1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise D'Aoust, MD</last_name>
      <phone>514-890-8000</phone>
      <email>louise_daoust@sympatico.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>McGill University</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3G 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Errol Marliss, MD</last_name>
      <phone>514) 843-1665</phone>
      <email>marliss.errol@muhc.mcgill.ca</email>
    </contact>
    <contact_backup>
      <last_name>Sylvie LeBourdias, RN</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>35392</phone_ext>
      <email>Sylvie.Lebourdais@muhc.mcgill.ca</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hotel-Dieu de Quebec</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-France Boudreault, RN</last_name>
      <phone>418-525-4444</phone>
      <email>marie-france.boudreault@chuq.qc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saskatchewan Adult HTPN Program</name>
      <address>
        <city>Regina</city>
        <state>Saskatchewan</state>
        <zip>S4T 1A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Stevenson, RN</last_name>
      <phone>+1-306-766-2746</phone>
      <email>Danielle.Stevenson@rqhealth.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Saqui O, Fernandes G, Allard JP. Quality of life analysis during transition from stationary to portable infusion pump in home parenteral nutrition patients: a Canadian experience. Nutr Clin Pract. 2014 Feb;29(1):131-41. doi: 10.1177/0884533613516129. Epub 2013 Dec 17.</citation>
    <PMID>24347531</PMID>
  </results_reference>
  <results_reference>
    <citation>Abdalian R, Fernandes G, Duerksen D, Jeejeebhoy KN, Whittaker S, Gramlich L, Allard JP. Prescription of trace elements in adults on home parenteral nutrition: current practice based on the Canadian Home Parenteral Nutrition Registry. JPEN J Parenter Enteral Nutr. 2013 May-Jun;37(3):410-5. doi: 10.1177/0148607112463074. Epub 2012 Oct 12.</citation>
    <PMID>23064256</PMID>
  </results_reference>
  <results_reference>
    <citation>Abdalian R, Saqui O, Fernandes G, Allard JP. Effects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition. JPEN J Parenter Enteral Nutr. 2013 Jul;37(4):538-43. doi: 10.1177/0148607112454543. Epub 2012 Jul 24.</citation>
    <PMID>22829428</PMID>
  </results_reference>
  <results_reference>
    <citation>Jawa H, Fernandes G, Saqui O, Allard JP. Home parenteral nutrition in patients with systemic sclerosis: a retrospective review of 12 cases. J Rheumatol. 2012 May;39(5):1004-7. doi: 10.3899/jrheum.110896. Epub 2012 Mar 1. Review.</citation>
    <PMID>22382342</PMID>
  </results_reference>
  <results_reference>
    <citation>Fernandes G, Kaila B, Jeejeebhoy KN, Gramlich L, Armstrong D, Allard JP. Canadian home parenteral nutrition (HPN) registry: validation and patient outcomes. JPEN J Parenter Enteral Nutr. 2012 Jul;36(4):407-14. doi: 10.1177/0148607111434599. Epub 2012 Feb 10.</citation>
    <PMID>22326909</PMID>
  </results_reference>
  <results_reference>
    <citation>Aljarallah B, Fernandes G, Jeejeebhoy KN, Gramlich LM, Whittaker JS, Armstrong D, Duerksen DR, Allard JP. The Canadian Home Total Parenteral Nutrition (HTPN) Registry: vitamin K supplementation and bone mineral density. JPEN J Parenter Enteral Nutr. 2012 Jul;36(4):415-20. doi: 10.1177/0148607111431983. Epub 2012 Feb 1.</citation>
    <PMID>22301331</PMID>
  </results_reference>
  <results_reference>
    <citation>Raman M, Gramlich L, Whittaker S, Allard JP. Canadian home total parenteral nutrition registry: preliminary data on the patient population. Can J Gastroenterol. 2007 Oct;21(10):643-8.</citation>
    <PMID>17948134</PMID>
  </results_reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2014</study_first_submitted>
  <study_first_submitted_qc>November 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <last_update_submitted>December 13, 2017</last_update_submitted>
  <last_update_submitted_qc>December 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Health Network, Toronto</investigator_affiliation>
    <investigator_full_name>Johane Allard</investigator_full_name>
    <investigator_title>MD, FRCPC</investigator_title>
  </responsible_party>
  <keyword>parenteral nutrition</keyword>
  <keyword>complications</keyword>
  <keyword>indications</keyword>
  <keyword>long-term administration</keyword>
  <keyword>HTPN</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

